Mevo Health uses proven GLP-1 and GIP/GLP-1 medications that help regulate appetite, slow digestion, improve blood sugar, and support safe weight loss. These include:
Semaglutide (active ingredient similar to Wegovy/Ozempic)
Tirzepatide (active ingredient similar to Zepbound/Mounjaro)
How they work:
Reduce appetite
Decrease food cravings
Improve satiety
Lower blood sugar
Support 15–20% weight loss for most patients
Compounding Disclaimer
Mevo Health partners with licensed U.S. pharmacies operating in FDA-registered, FDA-inspected 503A and 503B facilities.
The active pharmaceutical ingredients (APIs) come from FDA-approved manufacturers.
However:
Compounded semaglutide and tirzepatide are not FDA-approved medications.
They are custom formulations prepared in FDA-registered facilities following strict quality, potency, and sterility standards.
Your provider will determine which formulation is appropriate for you.